NUS
Nu Skin Enterprises, Inc.Marquee-fund ownership over time
This quarter's activity
New positions opened
Positions exited
None.
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Renaissance Technologies | Q3 2024(8Q snapshot) | 7Q | $9.61 | $5.86 | -39% |
| Citadel Advisors re-entered | Q3 2024(8Q snapshot) | 7Q | $9.16 | $5.86 | -36% |
| Two Sigma Investments | Q3 2024(8Q snapshot) | 7Q | $9.16 | $5.86 | -36% |
| D.E. Shaw | Q3 2024(8Q snapshot) | 7Q | $9.16 | $5.86 | -36% |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $9.16 | $5.86 | -36% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $9.16 | $5.86 | -36% |
| Point72 Asset Management re-entered | Q3 2025(8Q snapshot) | 3Q | $11 | $5.86 | -48% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Bridgewater Associates | Q3 2021 | Q1 2025 | → $6.15 | -86% |
| Coatue Management | Q1 2020 | Q2 2020 | → $27 | +13% |
| Maverick Capital | Q1 2019 | Q4 2019 | → $31 | -37% |
| Viking Global Investors | Q4 2013 | Q2 2014 | → $50 | -33% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at NU SKIN ENTERPRISES, INC.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Jun 3, 2026 — the most recent Form 4 on file — not from today.
- Form 40001021561-26-000061Jun 3, 2026
- Form 40001021561-26-000060Jun 3, 2026
- Form 40001021561-26-000059Jun 3, 2026
- Form 40001021561-26-000058Jun 3, 2026
- Form 40001021561-26-000057Jun 3, 2026
- Form 40001021561-26-000056Jun 3, 2026
- Form 40001021561-26-000055Jun 3, 2026
- Form 40001021561-26-000047May 12, 2026
- Form 40001021561-26-000042Mar 12, 2026
- Form 40001021561-26-000040Mar 9, 2026
- Form 40001021561-26-000038Mar 9, 2026
- Form 40001021561-26-000036Mar 9, 2026
- Form 40001021561-26-000034Mar 9, 2026
- Form 40001021561-26-000032Mar 9, 2026
- Form 40001021561-26-000030Mar 2, 2026
Fundamentals
XBRL · Nu Skin Enterprises, Inc.Annual figures sourced directly from Nu Skin Enterprises, Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for NU SKIN ENTERPRISES, INC. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KFORM 8-KMay 29, 2026
- 8-KFORM 8-KMay 8, 2026
- 10-QFORM 10-QMay 8, 2026
- 8-KFORM 8-KMay 7, 2026
- DEF 14A2026 PROXY STATEMENTApr 3, 2026
- 8-KFORM 8-KMar 27, 2026
- 8-KFORM 8-KMar 20, 2026
- 8-KFORM 8-KMar 9, 2026
- 10-KFORM 10-KFeb 13, 2026
- 8-KFORM 8-KFeb 12, 2026
- 10-QFORM 10-QNov 7, 2025
- 8-KFORM 8-KNov 6, 2025
- 10-QFORM 10-QAug 8, 2025
- 8-KFORM 8-KAug 7, 2025
- 8-KFORM 8-KMay 30, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q2 2026 | open | $6.12 | $5.86 | -4% |
| Point72 Asset Management | Q2 2026 | open | $6.12 | $5.86 | -4% |
| Citadel Advisors | Q4 2025 | Q1 2026 | $9.50 | $8.55 | -10% |
| Point72 Asset Management | Q3 2025 | Q1 2026 | $11 | $8.55 | -24% |
| Citadel Advisors | Q3 2024 | Q3 2025 | $9.16 | $11 | +23% |
| Two Sigma Investments | Q3 2024 | open | $9.16 | $5.86 | -36% |
| D.E. Shaw | Q3 2024 | open | $9.16 | $5.86 | -36% |
| AQR Capital Management | Q3 2024 | open | $9.16 | $5.86 | -36% |
| Millennium Management | Q3 2024 | open | $9.16 | $5.86 | -36% |
| Renaissance Technologies | Q3 2024 | open | $9.61 | $5.86 | -39% |
| Bridgewater Associates | Q3 2021 | Q1 2025 | $45 | $6.15 | -86% |
| Coatue Management | Q1 2020 | Q2 2020 | $24 | $27 | +13% |
| Maverick Capital | Q1 2019 | Q4 2019 | $49 | $31 | -37% |
| Viking Global Investors | Q4 2013 | Q2 2014 | $75 | $50 | -33% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.